PRODUCT ADHESION ISSUE

This adverse event was reported 35766 times

These drugs are most commonly taken by patients reporting PRODUCT ADHESION ISSUE:

# Drug Count
0 ESTRADIOL 6148
1 LIDOCAINE 3453
2 BUPRENORPHINE 3451
3 LIDOCAINE 4% 3439
4 LIDOCAINE PATCH 2863
5 ROTIGOTINE 1963
6 ESTRADIOL GEL 0.1% 1536
7 ESTRADIOL TRANSDERMAL 1536
8 ESTRADIOL, 1536
9 NICOTINE TRANSDERMAL SYSTEM PATCH 1252
See all common drugs associated with PRODUCT ADHESION ISSUE

PRODUCT ADHESION ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SCOPOLAMINE TRANSDERMAL SYSTEM 163 0.6105
1 LEVONORGESTREL/ETHINYL ESTRADIOL 553 0.5106
2 NORELGESTROMIN AND ETHINYL ESTRADIOL 708 0.3794
3 ESTRADIOL AND LEVONORGESTREL 668 0.3240
4 NICOTINE TRANSDERMAL SYSTEM PATCH 1252 0.2680
5 ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM 7 0.2500
6 ACTEMINOPHEN 1 0.2000
7 ROTIGOTINE 1963 0.1332
8 CLONIDINE TRANSDERMAL SYSTEM 187 0.0876
9 ESTRADIOL 6148 0.0710
See all drugs enriched for association with PRODUCT ADHESION ISSUE

PRODUCT ADHESION ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nonergot Dopamine Agonist [EPC] 1985 0.1271
1 Estrogen [EPC] 8141 0.0436
2 Amide Local Anesthetic [EPC] 3517 0.0403
3 Cholinergic Nicotinic Agonist [EPC] 2362 0.0386
4 Partial Opioid Agonist [EPC] 3452 0.0368
5 Antiarrhythmic [EPC] 3520 0.0353
6 Cholinergic Muscarinic Antagonist [EPC] 844 0.0215
7 l-Thyroxine [EPC] 1 0.0204
8 Progesterone [EPC] 477 0.0201
9 l-Triiodothyronine [EPC] 1 0.0196
See all drug classes enriched for association with PRODUCT ADHESION ISSUE